|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0006826,
umls-concept:C0017387,
umls-concept:C0030705,
umls-concept:C0034866,
umls-concept:C0175674,
umls-concept:C0543467,
umls-concept:C0920321,
umls-concept:C1441547,
umls-concept:C1514468,
umls-concept:C1516225,
umls-concept:C1517586,
umls-concept:C1521827,
umls-concept:C2587213
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
1994-1-25
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0959-8049
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29A
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1907-10
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8260253-Animals,
pubmed-meshheading:8260253-Antineoplastic Agents,
pubmed-meshheading:8260253-Clinical Trials, Phase I as Topic,
pubmed-meshheading:8260253-Consumer Product Safety,
pubmed-meshheading:8260253-DNA, Recombinant,
pubmed-meshheading:8260253-Drug Labeling,
pubmed-meshheading:8260253-Humans,
pubmed-meshheading:8260253-Recombinant Proteins,
pubmed-meshheading:8260253-Recombination, Genetic
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials.
|
|
pubmed:affiliation |
University Department of Clinical Oncology, Royal Free Hospital School of Medicine, London, U.K.
|
|
pubmed:publicationType |
Journal Article,
Guideline,
Practice Guideline
|
